Please login to the form below

Not currently logged in
Email:
Password:

Sun Pharma

This page shows the latest Sun Pharma news and features for those working in and with pharma, biotech and healthcare.

BMS psoriasis drug hits the mark in phase II

BMS psoriasis drug hits the mark in phase II

including Johnson &Johnson’s Stelara (ustekinumab) and follow-up Tremfya (guselkumab), Sun Pharma’s Ilumya (tildrakizumab) and AbbVie’s recently-filed risankizumab.

Latest news

More from news
Approximately 6 fully matching, plus 44 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    295. Novartis (Switzerland). Sun Pharma (India). Asset acquisition. Odomzo (sonidegib; hedgehog pathway inhibitor), approved in basal cell carcinoma. ... Sun Pharma. 3.5%. BSN Medical. Svenska Cellulosa. -0.7%. Claris. Baxter. -1.3%.

  • Deal Watch November 2016 Deal Watch November 2016

    Sun Pharma will also assume Biosintez's $36m debt as part of this transaction. ... acquisition - company. 78. JSC Biosintez/ Sun Pharma. Russian pharma focusing on hospital segment with 2015 revenues of approx $52m. ††

  • Choosing destiny Choosing destiny

    to, for example, Sun Pharma and vice-versa.

  • Deal Watch July 2016 Deal Watch July 2016

    In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below). ... Almirall paid $50m upfront to Sun Pharma for a licence to tildrakizumab (an IL-23p19 antibody)

  • Pharma deals during April 2014 Pharma deals during April 2014

    This may not be as simple as it seems. Last year the FDA imposed export bans from 20 or so plants in India and warned several others, and whilst Sun Pharma ... Doctors have shied away from Ranbaxy brands in recent years and it is rumoured that a solution

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • How To Become an MSL – Online Training

    Michael Milane, MD, MBA DUSA Pharmaceuticals, a SUN Pharma company . Executive Director of Medical Affairs Jennifer Williams, PhD, JD, MBA, MS, RN Bard Medical Director of Medical Science Liaisons.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics